This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
Their severe trial will be the one that either sinks the ship or blasts it forward. It'll be hard to ignore a company reducing death percentage versus placebo by X percentage. The endpoint doesn't leave much to be interrupted, imo.
Seems we're the bridesmaid, never the bride. What are we not seeing? A step too far for the gov to get on board with an OTC stock? Has NP burned too many bridges? Are there accounting issues?
We're an OTC stock with a product that has never been approved for anything accompanied by a bumbling huckster idiot CEO.
Late September? Where did it even say that? The press release talks about enrollment which appears to have not even started yet. Maybe late September could be the case, but I agree with your point that LeBron’s data will be in hand already before there are any results from this.
If CYDY results are good, combining remdesiver with leronlimab would be more straightforward as the testing has already started for leronlimab.
At least someone else noticed that. If I am Humanigen, it looks like you are just happy to be included and this is the government trying to keep Remdesivir in the $$$.
If the results are good you can just treat with LeBron and not add a drug with side effects.
That’s true but the stocks at $5.50 because of covid. Fails to be useful for that and it’s back to a buck or two a share.
It's possible the combo could be better than either alone for some folks. Hard to say. All depends on the results
Rem is on borrowed time and they know it. It won't be long before multiple drugs prove to be much more effective.
Sure are cashing in and they have moved rapidly to do so in the time they have. Trump touts it in his briefing
Yep. A failed drug for multiple indications. Failed a Covid Trial in China in March. Began a new trial in the US. Changed the primary end-point with two weeks to go in the US trial. Fails on almost all end-points except for days in hospital (beats placebo by 3 or 4 days). And is fast-track approved.
If LL fails against COVID, I'll be selling for whatever I can get for my shares.
Worldwide there is 2M new cases each year. At 150K triple negative's taking a shot a week for a full year. Lets say 52K per person. That's 7.8B per year.
Well they said they are going to discuss it so it should be something at least. Thursday at 4 is going to be wild, amazon reports then too I may actually have a stroke.
I really did like that thoughtful investing fellow but in the past week he’s turned into this theory that trump is going to announce us and they’re just waiting till it’s all lined up and now I can never take him serious again. He actually thinks that will happen by Thursday.
I heard Trump today and he mentioned a few times that they will be announcing developments on therapeutics in the next week or two. It is not out of the question that CYDY is one he is talking about.
It’s not out of the question, but it’s wishful thinking.
Thoughtful Investing puts a lot of work into his posts but they are often based on faulty assumptions. For instance, he'll have elaborate posts about institutional investing. But then he'll explain that the way he determines what is an institutional investment is any buy or sell of 10,000 shares or more is an institutional investment. Obviously, a trade of 10,000 shares does not mean it's an institution. Yesterday, he was talking about there being 3 short attacks because 50k, 65k, and 100k shares were traded. Again, someone selling that many shares isn't necessarily shorting or even likely shorting.
Right. Exactly. He is constantly worried about short attacks but does have some good info, definitely better than anybody else there. But the trump thing is just too much for me.
That’s why I sold @ 1/3 at 6.40. Just protecting myself in case of bad news. I’d hate to lose all my gains but worst case scenario is even. Best case is a really good.
This is such a key point. Take your profits if you are getting cold feet. If your cost basis is north of $6, this post is not for you.
I have enough friends, need more money.
My guess is that they missed on the primary endpoint but hit on some of the secondary ones. Now they need to convince the FDA that the results still show it to be an improvement over Rem.
It's not fear shtick, the man isn't who you want leading a company to save the world. Furthermore, not knowing and being cognizant of your weaknesses does make you an incompetent moron.
Because he is exhibiting patience in order to further boost the stock price with one blowout PR release? If he knows the results are good he doesn’t have to be some impatient stockholder.
![[icon]](/data/avatars/m/5/5167.jpg?1660313464){kind=avatar}
